Anons, I heard a radio advertisement today that shocked and disturbed me. It has to do with a chemical called Colchicine.
Colchicine is a mutagen, and is extremely toxic in low dosages. It is used to treat one condition, and one condition only, a form of gout.
The advertisement I heard was an international funded study to determine the efficacy of Colchicine to treat China Virus!
Below will be two links, one is a snippet from Wikipedia describing the toxicity of Colchicine, and the other is a Fox News article about the study.
Make of it what you will, but my understanding is that this is insanity as Colchicine causes direct and uncontrolled mutation of DNA in all cases.
>>Toxicity:
According to one review, colchicine poisoning by overdose (range of acute doses of 7 to 26 mg) begins with a gastrointestinal phase occurring 10–24 hours after ingestion, followed by multiple organ dysfunction occurring 24 hours to 7 days after ingestion, after which the affected person either declines into multi-organ failure or recovers over several weeks.[29]
Colchicine can be toxic when ingested, inhaled, or absorbed in the eyes.[14] Colchicine can cause a temporary clouding of the cornea and be absorbed into the body, causing systemic toxicity. Symptoms of colchicine overdose start 2 to 24 hours after the toxic dose has been ingested and include burning in the mouth and throat, fever, vomiting, diarrhea, and abdominal pain.[19] This can cause hypovolemic shock due to extreme vascular damage and fluid loss through the gastrointestinal tract, which can be fatal.
>>https://en.m.wikipedia.org/wiki/Colchicine
>New trial to test if anti-inflammatory drug colchicine prevents COVID-19 complications
By Christopher Carbone
Fox News
A new international trial will examine whether a common anti-inflammatory drug known as colchicine could ward off COVID-19 symptoms and potentially prevent the need for hospitalization for some patients.
The study, which has the University of California-San Francisco and New York University School of Medicine as its first two clinical test sites, aims to enroll 6,000 newly diagnosed patients over age 40 and with at least one additional risk factor for serious COVID-19 complications, such as chronic pulmonary disease, heart disease, or age greater than 70 years.
“This is one of the very few COVID-19 trials designed specifically for patients who have not yet been hospitalized,” said Priscilla Hsue, a professor of medicine at UCSF and principal investigator for the UCSF study site, in a statement. “We suspect that early treatment, before the onset of severe symptoms requiring hospitalization, may provide the best chance to improve outcomes. By the time extensive lung damage has developed, it may be too late to intervene successfully.”
Colchicine, which is inexpensive and widely available, has been prescribed for many years to treat gout by reducing joint pain and swelling, according to researchers.
>https://www.foxnews.com/science/at-home-study-to-test-if-common-drug-prevents-covid-19-complications.amp